The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease

被引:20
|
作者
Wang, Yan [1 ]
Lin, Fang [1 ]
Qin, Zheng-Hong [1 ]
机构
[1] Soochow Univ, Sch Med, Dept Pharmacol, Lab Aging & Nervous Dis SZS0703, Suzhou 215123, Peoples R China
基金
中国国家自然科学基金;
关键词
Huntington's disease; huntingtin; modification; SUMOylation; phosphorylation; palmitoylation; acetylation; NUCLEAR-PORE COMPLEX; MUTANT-HUNTINGTIN; REPRESSES TRANSCRIPTION; PROTEIN MODIFICATION; AGGREGATE FORMATION; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; CASPASE CLEAVAGE; REDUCES TOXICITY; BINDING-PROTEIN;
D O I
10.1007/s12264-010-1118-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Post-translational modifications are rapid, effective and reversible ways to regulate protein stability, localization, function, and their interactions with other molecules. Post-translational modifications usually occur as chemical modifications at amino acid residues, including SUMOylation, phosphorylation, palmitoylation, acetylation, etc. These complex biochemical modifications tightly regulate and control a variety of cellular processes. Several forms of post-translational modifications of huntingtin (Htt) have been described. These modifications affect Htt metabolism, protein-protein interactions and cellular toxicity. Cleavage and clearance of mutant Htt, and the interactions between mutant Htt and other cellular proteins are important biochemical events leading to Huntington's disease (HD). Therefore, identifying signaling pathways of Htt modification and evaluating the significance of Htt modifications would lead to a better understanding of the normal function of wild-type Htt and the pathogenic mechanisms of mutant Htt.
引用
收藏
页码:153 / 162
页数:10
相关论文
共 50 条
  • [1] Protective effect of GM1 in Huntington's disease: the role of mutant huntingtin post-translational modifications
    Maglione, V.
    Di Pardo, A.
    Horkey, M.
    Sipione, S.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2012, 90 (06) : 672 - 672
  • [2] ARGININE METHYLATION OF HUNTINGTIN IS A NOVEL POST-TRANSLATIONAL MODIFICATION THAT IMPACTS HUNTINGTON'S DISEASE PATHOGENESIS
    Migazzi, Alice
    Tripathy, Debasmita
    Scaramuzzino, Chiara
    Pandey, Udai Bhan
    Saudou, Frederic
    Pennuto, Maria
    Basso, Manuela
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A5 - A6
  • [3] Protective Proteolysis in Huntington's Disease: Unraveling the Role of Post-Translational Myristoylation of Huntingtin in Autophagy
    Alshehabi, Yasmeen
    Martin, Dale D. O.
    JOURNAL OF HUNTINGTONS DISEASE, 2024, 13 (03) : 267 - 277
  • [4] Role of Post-translational Modifications in Alzheimer's Disease
    Ramesh, Madhu
    Gopinath, Pushparathinam
    Govindaraju, Thimmaiah
    CHEMBIOCHEM, 2020, 21 (08) : 1052 - 1079
  • [5] Histone Post-translational Modifications in Huntington's and Parkinson's Diseases
    Pena-Altamira, Luis Emiliano
    Polazzi, Elisabetta
    Monti, Barbara
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (28) : 5085 - 5092
  • [6] The Role of Post-translational Modifications on the Energy Landscape of Huntingtin N-Terminus
    Yalinca, Havva
    Gehin, Charlotte Julie Caroline
    Oleinikovas, Vladimiras
    Lashuel, Hilal A.
    Gervasio, Francesco Luigi
    Pastore, Annalisa
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2019, 6
  • [7] Mutant Huntingtin Derails Cysteine Metabolism in Huntington's Disease at Both Transcriptional and Post-Translational Levels
    Paul, Bindu D.
    Sbodio, Juan I.
    Snyder, Solomon H.
    ANTIOXIDANTS, 2022, 11 (08)
  • [8] The role of oxidative post-translational modifications in type 1 diabetes pathogenesis
    Alhamar, Ghadeer
    Vinci, Chiara
    Franzese, Valentina
    Tramontana, Flavia
    Le Goux, Nelig
    Ludvigsson, Johnny
    Nissim, Ahuva
    Strollo, Rocky
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [9] Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease
    Mumtaz, Ibtisam
    Ayaz, Mir Owais
    Khan, Mohamad Sultan
    Manzoor, Umar
    Ganayee, Mohd Azhardin
    Bhat, Aadil Qadir
    Dar, Ghulam Hassan
    Alghamdi, Badrah S.
    Hashem, Anwar M.
    Dar, Mohd Jamal
    Ashraf, Gulam Md.
    Maqbool, Tariq
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [10] Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson's disease
    Yoo, Hajung
    Lee, Jeongmin
    Kim, Bokwang
    Moon, Heechang
    Jeong, Huisu
    Lee, Kyungmi
    Song, Woo Jeung
    Hur, Junho K.
    Oh, Yohan
    BMB REPORTS, 2022, 55 (07) : 323 - 335